(Q43039814)

English

A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.

scientific article published in December 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

immunosuppression

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Timothy L Pruett

11

object named as

Timothy L Pruett

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

16

object named as

John M Ham

0 references

John P. Roberts

12

object named as

John Roberts

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Elizabeth A. Pomfret

7

object named as

Elizabeth A Pomfret

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Göran B Klintmalm

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Gary L Davis

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Lewis Teperman

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

George J Netto

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kenneth Washburn

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Stephen M Rudich

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hugo E Vargas

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Robert Brown

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Devin Eckhoff

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

David C Mulligan

13

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Michael R Charlton

14

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Thomas G Heffron

15

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

David D Douglas

17

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Linda Sher

18

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Prabhakar K Baliga

19

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Milan Kinkhabwala

20

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Baburao Koneru

21

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Michael Abecassis

22

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Michael Millis

23

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Linda W Jennings

24

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Carlos G Fasola

25

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Liver Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1394-1403

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

The association between hepatitis C infection and survival after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Predictors of patient and graft survival following liver transplantation for hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

A novel three-dose regimen of daclizumab in liver transplant recipients with hepatitis C: a pharmacokinetic and pharmacodynamic study

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Antiviral treatment withdrawal in viremic HCV-positive liver transplant patients: impact on viral loads, allograft function and morphology

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Corticosteroid-free immunosuppression in liver transplantation: a meta-analysis and meta-regression of outcomes.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Impact of steroids on hepatitis C virus replication in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: results of a prospective randomized study

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Preliminary analysis of early outcomes of a prospective, randomized trial of complete steroid avoidance in liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Contribution of obesity to hepatitis C-related fibrosis progression

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FLT.22417

21 January 2018

Identifiers

10.1002/LT.22417

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43039814&oldid=1658002833"